• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Colonoscopy could be costeffectiveonly in middle age

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 30 No 12
Volume 30
Issue 12

New evidence suggests conducting screening colonoscopies for people in their mid- 50s saves money. But other evidence indicates there may be an upper age limit for the benefits of such screening.

New evidence suggests conducting screening colonoscopies for people in their mid- 50s saves money. But other evidence indicates there may be an upper age limit for the benefits of such screening.

Dr. Jianjun Li and colleagues from Maimonides Medical Center in Brooklyn conducted free screening colonoscopies for 248 consecutive patients with a mean age of 55. Follow-up detected colon cancer and large polyps in about one in 10.The screening program cost $390,000. Had these patients not been screened, their delayed treatment would have cost Medicare nearly $1.3 million. Li released results at the 2008 American College of Gastroenterology meeting.

On the other hand, the U.S. Preventive Services Task Force, an independent panel of the Department of Health and Human Services, recommended that screening cease when men reach age 75, when the possible harm from screening outweighs its benefits. The task force report was published in the Annals of Internal Medicine (2008;149[3]: 185-191).

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.